A7986
阿托伐醌
≥98% (HPLC), powder, anti-protozoal agent
别名:
Mepron, 反式-2-[4-（4-氯苯基）环己基]-3-羟基-1,4-萘二酮
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C22H19ClO3
化学文摘社编号:
分子量:
366.84
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
产品名称
阿托伐醌, ≥98% (HPLC)
Quality Segment
assay
≥98% (HPLC)
form
powder
color
yellow
solubility
DMSO: >10 mg/mL
originator
GlaxoSmithKline
storage temp.
−20°C
SMILES string
OC1=C([C@H]2CC[C@@H](CC2)c3ccc(Cl)cc3)C(=O)c4ccccc4C1=O
InChI
1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,26H,5-8H2/t13-,15-
InChI key
KUCQYCKVKVOKAY-CTYIDZIISA-N
Application
Atovaquone inhibits the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket. In addition to its use as a treatment for toxoplasmosis, atovaquone has antimalarial properties and prevents pneumocystis pneumonia post-renal transplant.
Biochem/physiol Actions
抗原生动物线粒体电子传递抑制剂中的阿托伐醌。 它还具有抗疟药和抗肺囊虫药的作用。
阿托伐醌是一种抗原生动物线粒体电子传递抑制剂；抗疟药；抗肺囊虫药，也已用于治疗弓形虫病。它是原生动物线粒体蛋白泛醌的类似物，并通过与泛醇氧化口袋中的Rieske铁硫蛋白和细胞色素b相互作用抑制细胞色素bc（1）复合物起作用。
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Still not finding the right product?
Explore all of our products under 阿托伐醌
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
商品
Bioactive small molecules for immune system signaling target identification/validation and antibiotics, antivirals, and antifungals offered.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| A7986-10MG | 04061833390894 |
| A7986-50MG | 04061833390900 |